Source: HealthIT Answers The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede
Source: Pharmaceutical Outsourcing In the fast-paced world of biopharmaceuticals, emerging and mid-market companies face significant challenges when bringing innovative drugs to market. One major obstacle
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Clinical trials are the long and complex process by which biopharmaceutical companies must prove the safety and efficacy of investigational new therapies to FDA before
Source: Nashville Medical News Between logistical burdens, distrust in the healthcare system, and lack of awareness and information in many non-English languages, key demographic groups
Source: Yahoo Finance MARKET INSIGHTS The virtual clinical trials market is one of the innovative approaches for traditional clinical trials, through remote monitoring and more
Source: ReportLinker Summary The global virtual clinical trials market is expected to grow at a CAGR of 17.59% during 2022-2027. MARKET INSIGHTS The virtual clinical
Patient recruitment is a major barrier in clinical trials. This involves the identification of patients, screening them for inclusion/exclusion criteria of a given clinical trial,
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on
Wed, October 26, 2022 at 5:35 PM-6 min read Clinical trials rely on volunteer populations that can be challenging to access and monitor. Inadequate diversity
